Top 10 Up And Coming Stocks To Own Right Now

To become a better investors, you need to put together a winning team that includes a strong brokerage company in your corner. But how can you pick the right broker for your needs?

In the following video, Fool contributor and personal finance expert Dan Caplinger discusses the things to consider in choosing a broker. With so much riding on your choice, it's important to look beyond stock commissions to get a sense of the true costs that you'll pay for your portfolio. In addition, by evaluating research and other services that each broker offers, you can simplify your own finances by consolidating accounts at one broker if you want.

Commission-free ETFs are a key part of brokers' offerings. To learn more about a few ETFs that have great promise for delivering profits to shareholders, check out The Motley Fool's special free report, "3 ETFs Set to Soar." Just click here to access it now.

Top 10 Up And Coming Stocks To Own Right Now: Strattec Security Corporation(STRT)

Strattec Security Corporation engages in the design, development, manufacture, and marketing of automotive access control products. The company?s products include mechanical locks and keys, electronically enhanced locks and keys, steering column and instrument panel ignition lock housings, latches, power sliding door systems, power lift gate systems, power deck lid systems, door handles, and related products. It also provides full service and aftermarket support for its products. The company offers its products primarily for automotive manufacturers. It markets its products in the United States, Canada, Mexico, Europe, South America, Korea, and China. The company was founded in 1994 and is headquartered in Milwaukee, Wisconsin.

Advisors' Opinion:

• [By Martin Vlcek]

  Strattec Security Corp. (STRT) is a growing small-cap company with more than 100 years in the automotive supply industry and strong sales growth since 2009. The success and growth of Strattec are still mostly influenced by the global automotive markets. As many analysts still predict ongoing industry growth, the company is poised to continue strongly benefiting from this automotive tailwind. However, the company's recent diversification efforts into new product lines, industries outside of automotive and countries outside of the U.S. have created multiple new growth drivers that will ensure Strattec's continued robust sales and EPS expansion. The company's growth has also become much more balanced and more resilient to a potential automotive industry shock or U.S. slowdown.

• [By Monica Wolfe]

  Strattec Security (STRT)

  Last week Mario Gabelli increased his position in Strattec Security. The guru increased his position 4.82% by adding a total of 13,136 shares to his holdings. He bought these shares at an average price of $43.15, and since then the price per share has increased approximately 5%.

Top 10 Up And Coming Stocks To Own Right Now: Changyou.com Limited(CYOU)

Changyou.com Limited develops and operates online games in the People?s Republic of China. It involves in the development, operation, and licensing of massively multi-player online role-playing games (MMORPGs), which are interactive online games that might be played simultaneously by various game players. The company operates seven MMORPGs that include its in house developed Tian Long Ba Bu; and licensed Blade Online, Blade Hero 2, Da Hua Shui Hu, Zhong Hua Ying Xiong, Immortal Faith, and San Jie Qi Yuan. As of December 31, 2010, Changyou?s games in China had approximately 111.4 million aggregate registered accounts; 1.0 million aggregate peak concurrent users; and 2.7 million aggregate active paying accounts. The company was founded in 2003 and is based in Beijing, the People?s Republic of China. Changyou.com Limited is a subsidiary of Sohu.com Inc.

Advisors' Opinion:

• [By Kevin Chen]

  To be fair, these revenues come from their stake in game company Changyou (NASDAQ: CYOU  ) . Because Sohu owns a majority stake in Changyou, Sohu must consolidate all financials into its statements -- even as Changyou is independently listed on stock exchanges. Whatever the case, Sohu actually created Changyou -- it started as a business unit in 2003, then was spun out in 2007. In any case, Sohu should do some serious soul-searching.

• [By Damian Illia]

  In the video game industry no one is playing games. Users are seeking entertainment on all kinds of devices, and companies strive hard to stand out and profit in this shifting field. Competition might be stiff, but it�� a highly profitable business for those that make it to the next level. Electronic Arts (EA), Changyou.com (CYOU) and Activision Blizzard (ATVI) are three game developers with different, but interesting, prospects ahead. Let�� take a closer look at them and see if you��e up for play:

• [By Yiannis Mostrous]

  Changyou.com (CYOU)

  A subsidiary of Internet portal Sohu.com, video game developer Changyou.com specializes in massively multiplayer online role-playing games (MMORPG).

Top 5 Growth Stocks To Buy Right Now: Flotek Industries Inc (FTK)

Flotek Industries, Inc. (Flotek), incorporated on May 17, 1985, is a diversified global supplier of drilling and production related products and services. Its core focus is oilfield specialty chemicals and logistics, down-hole drilling tools and down-hole production tools used in the energy and mining industries. Flotek operates in three segments: Chemicals and Logistics, Drilling Products and Artificial Lift. The Company operates using third party agents in Canada, Mexico, Central America, South America, the Middle East, and Asia. In May 2013, Flotek Industries Inc through its wholly owned subsidiary acquired the entire share capital of Florida Chemical Co Inc.

Chemicals and Logistics

The chemical business provides oil and natural gas field specialty chemicals for use in drilling, cementing, stimulation and production activities. The Company�� specialty chemicals are manufactured to withstand a range of down-hole pressures, temperatures and other well-specific conditions. Flotek operates two laboratories, a technical services laboratory and a research and development laboratory, which focus on design, development and testing of new chemical formulations and enhancement of existing products, often in cooperation with the customers. Its micro-emulsions are stable mixtures of oil, water and surface active agents, forming complex nano-fluids, in which the molecules are organized into nanostructures. The micro-emulsions are composed of renewable plant derived cleaning ingredients and oils and are biodegradable. Flotek�� logistics business designs, project manages and operates automated bulk material handling and loading facilities. These bulk facilities handle oilfield products, including sand and other materials for well-fracturing operations, dry cement and additives for oil and gas well cementing, and supply materials used in oilfield operations.

Drilling Products

Flotek is a provider of down-hole drilling tools used in the oilfield, min! ing, water-well and industrial drilling activities. It manufactures, sells, rents and inspects specialized equipment for use in drilling, completion, and production and workover activities. The rental tools include stabilizers, drill collars, reamers, wipers, jars, shock subs, wireless survey, and measurement while drilling (MWD) tools and mud-motors. Equipment sold primarily includes mining equipment, centralizers and drill bits. Flotek focuses its product marketing primarily in the Southeast, Northeast, Mid-Continent and Rocky Mountain regions of the United States, with international sales conducted through third party agents.

Artificial Lift

Flotek provides pumping system components, electric submersible pumps (ESPs), gas separators, production valves and services. The products address the needs of coal bed methane and traditional oil and gas production to move gas, oil and other fluids from the producing horizon to the surface. The Artificial Lift products employ technologies to improved performance. The Petrovalve product optimizes pumping efficiency in horizontal completions, heavy oil and wells with high liquid to gas ratios. Artificial Lift products are manufactured in China, assembled domestically and distributed globally.

Advisors' Opinion:

• [By David Smith]

  Flotek Industries (NYSE: FTK  )
  I've mentioned Flotek Industries to Fools in the past. The relatively small ($940 million capitalization and growing) company provides a range of products and assistance for oil and gas operations, from well construction to production. It's also the only services company -- and one of but a handful of companies in any sector -- that's been accorded a perfect consensus of one (strong buy) by the analysts.

• [By David Smith]

  Flotek Industries (NYSE: FTK  )
  The smallest member of the trio, with a market cap of about $815 million, Flotek operates on the services side of the energy sector. As I've previously pointed out to Fools, it also constitutes a rare instance wherein the analysts who monitor the company all accord it strong buy ratings. But with Flotek's share price having risen by more than 40% year to date, it is difficult to contest that unanimous confidence.

Top 10 Up And Coming Stocks To Own Right Now: Atmel Corporation(ATML)

Atmel Corporation designs, develops, manufactures, and sells semiconductor integrated circuit (IC) products. The company?s Microcontrollers segment provides various proprietary and standard microcontrollers, such as Atmel?s capacitive touch products, including maXTouch and QTouch, AVR 8-bit and 32-bit products, ARM-based products, and Atmel?s 8051 8-bit products. Its Nonvolatile Memories segment offers serial interface electrically erasable programmable read-only memory and serial interface flash memory products; and parallel interface flash memories, as well as parallel interface electrically erasable programmable read-only memory and erasable programmable read-only memory devices. The company?s Radio Frequency and Automotive segment provides products designed for the automotive industry, including automobile electronics, networking and access systems, and engine, lighting, and entertainment components. This segment produces and sells wireless and wired devices for in dustrial, consumer, and automotive applications; and offers foundry services, which produce radio frequency products for the mobile telecommunications market. Its Application Specific Integrated Circuit segment provides custom application specific ICs designed to meet specialized single-customer requirements of high performance devices in a range of specific applications. This segment provides products that provide hardware security for embedded digital systems; and products with military and aerospace applications, as well as develops application specific standard products for space applications, power management, and secure crypto memory products. The company sells its products directly to original equipment manufacturers; and indirectly through a network of distributors. It has operations in the United States, Asia, Europe, South Africa, and Central and South America. Atmel Corporation was founded in 1984 and is headquartered in San Jose, California.

Advisors' Opinion:

• [By Srdjan Bejakovic]

  In the first quarter, semiconductor maker Atmel� (NASDAQ: ATML  ) recorded $337 million in revenue, $7 million above the upper end of its own guidance range. Additionally, management claims that 2014 will be a year of growth and increased profitability for the company, driven by continuing demand for microcontrollers and an improving picture in Atmel's touch business. What's lying behind the surprising revenue numbers, and can Atmel prosper in spite of increasing competition from such solid companies as Microchip Technologies� (NASDAQ: MCHP  ) and Synaptics (NASDAQ: SYNA  ) ?

• [By John Udovich]

  If you are looking for a semiconductor stock that�� focus on an area that�� not so cyclical, mid cap microcontroller (MCU) stock Atmel Corporation (NASDAQ: ATML) could be a good choice���meaning its worth taking a closer look at the stock along with other�microcontroller�players like Microchip Technology Inc (NASDAQ: MCHP), STMicroelectronics N.V. (NYSE: STM) and Cypress Semiconductor Corporation (NASDAQ: CY). Microcontrollers are programmable and�embedded�chips that are increasingly�hidden inside a all sorts of products these days e.g. if you have an appliance�with a�LED or LCD screen and a keypad, it contains some kind of�microcontroller plus all new�automobiles contain at least one�and often several. I should mention that we have also recently added Atmel Corporation to our SmallCap Network Elite Opportunity (SCN EO) portfolio and we are down about 5.6% mostly due to the recent market volatility.

• [By MONEYMORNING.COM]

  XSD holds such big-cap names as Texas Instruments Inc. (Nasdaq: TXN) and Intel Corp. (Nasdaq: INTC). It also owns Atmel Corp. (Nasdaq: ATML), which has a market cap of less than $4 billion, and Silicon Laboratories Inc. (Nasdaq: SLAB), with a market cap of $2 billion.

• [By GuruFocus]

  George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated

Top 10 Up And Coming Stocks To Own Right Now: Rowan Companies Inc.(RDC)

Rowan Companies, Inc. provides onshore and offshore oil and gas contract drilling services in the United States and internationally. The company offers its contract drilling services through its fleet of 28 self-elevating mobile offshore drilling platforms and 30 deep-well land drilling rigs. The company was founded in 1923 and is headquartered in Houston, Texas.

Advisors' Opinion:

• [By Ben Levisohn]

  A bad year for offshore drillers is likely to get worse–and Morgan Stanley says even market favorite Rowan (RDC) could get hit. It recommends yield plays, including Seadrill (SDRL).

• [By Ben Levisohn]

  As a result, Gerry cut Atwood Oceanics, Ensco (ESV) and Noble Energy (NE) to Market Perform from Outperform. He raised Rowan (RDC) to Outperform from Market Perform. Rowan was also a favorite of Barclays.

• [By Ben Levisohn]

  This year started so badly for Seadrill (SDRL), Transocean (RIG) and Rowan (RDC) and other offshore drillers that it shouldn’t come as a surprise that some investors are seeing value in their beaten down shares. The folks at Raymond James, however, see conditions at offshore drillers getting worse before they get better.

• [By Monica Wolfe]

  Rowan Companies PLC (RDC)

  FPA Capital's second largest position goes to Rowan Companies where the guru holds on to a total of 2,065,700 shares. Their position in the company represents 9.5% of the fund's total assets managed and 1.66% of the company�� shares outstanding.

Top 10 Up And Coming Stocks To Own Right Now: Stemline Therapeutics Inc (STML)

Stemline Therapeutics, Inc. (Stemline), incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target both cancer stem cells (CSCs) and tumor bulk. The Company is developing two clinical-stage product candidates, SL-401 and SL-701, for which it holds global marketing rights. The indication for SL-401, a biologic-drug conjugate, is acute myeloid leukemia (AML). The indications for SL-701, a synthetic peptide vaccine, are pediatric and adult brain cancer. It has a platform, StemScreen, for the discovery of CSC-targeted compounds, from which it has discovered or validated several of its clinical and preclinical product candidates. Stemline�� StemScreen consists of StemScreen-1 and StemScreen-2 for the identification of CSC-directed compounds.

SL-301 is a small molecule gamma-secretase inhibitor that inhibits Notch, a pathway expressed by CSCs and tumor bulk of multiple cancer types. SL-101 is a monoclonal antibody-based (mAb -based) compound that targets CD123 and has shown in vitro activity against certain hematologic cancers. SL-201 is a small molecule active against certain hematologic and solid tumor types. SL-601 is a mAb-based compound that targets a cell surface marker on bladder CSCs, which is also expressed on a variety of other solid tumor types. It has also in-licensed certain intellectual property directed to mAb-based therapeutics to validated oncology targets, including Glypican-3, Tie-1, CD133, Frizzled, Smoothened and Patched.

SL-401 - An IL-3R-Directed Compound Targeting Cancer Stem Cells and Tumor Bulk

SL-401 is a clinically active biologic-drug conjugate consisting of human interleukin-3 (IL-3) genetically linked to a truncated version of diphtheria toxin. SL-401 targets the IL-3 receptor (IL-3R), which is overexpressed on both the CSCs and tumor bulk of multiple hematologic cancers, including AML. SL-401 has demonstrated preclinical in vit! ro and in vivo activity against both leukemia blasts (which includes tumor bulk) and CSCs of a range of human leukemia cell lines and primary leukemia cells from patients.

SL-701

SL-701 is a clinically active synthetic peptide vaccine that targets several epitopes on CSCs and tumor bulk of brain cancer. In two completed Phase 1/2 clinical trials, SL-701 demonstrated single agent anti-tumor activity in pediatric patients with newly diagnosed brainstem glioma (BSG) and other high-grade gliomas (HGGs) and in adult patients with refractory or recurrent GBM, and other HGGs.

StemScreen-1

StemScreen-1 is a drug discovery platform designed to identify CSC-targeted compounds based on the isolation of CSCs and evaluation of CSC gene expression profiles. CSCs are isolated from primary tumor tissue or cell lines, and then subjected to gene expression analysis using a variety of technologies, including microarray. A control tissue, such as normal bone marrow is analyzed as a comparator against the gene expression profile of the isolated CSCs. These data are then interfaced with an information base of compounds and their mechanisms of action (that is which gene products and pathways they impact). It has utilized StemScreen-1 to discover a number of its preclinical drug candidates. These include SL-201, SL-301, and SL-601. In addition, SL-401 demonstrated activity against CSCs as determined by both an in vitro colony formation and in vivo animal implantation assay, thereby validating certain StemScreen-1 anti-CSC assays.

StemScreen-2

StemScreen-2 is a high throughput drug discovery platform it is developing to discover anti-CSC compounds. StemScreen-2 utilizes a cell-based assay that can track and follow CSCs in their natural state during high throughput screening. In particular, StemScreen-2 utilizes a CSC-specific promoter linked to a reporter as a method for identifying and following CSCs in their native environment of surrounding tumor b! ulk. In t! his way, StemScreen-2 enables the identification of compound hits, in a high throughput manner, with anti-CSC activity.

The Company competes with Boston Biomedical, Inc., Eclipse Therapeutics, Inc., OncoMed Pharmaceuticals, Inc., Verastem, Inc., Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Dainippon Sumitomo Pharma Co. Ltd., Geron Corp., GlaxoSmithKline plc, ImmunoCellular Therapeutics, Ltd, Macrogenics Inc., Amgen, Inc., Pfizer Inc., Roche Holding AG, Sanofi U.S. LLC., Cyclacel Pharmaceuticals, Inc., Sunesis Pharmaceuticals Inc., Clavis Pharma ASA, Ambit Biosciences Corporation, Celgene Corporation, Eisai Co. Ltd., Celator Pharmaceuticals, Inc., Merck & Co., Inc., Eisai Co., Inc., Roche Holding AG, Novartis AG and Celldex Therapeutics, Inc.

Advisors' Opinion:

• [By Keith Speights]

  Best-performing biotech IPO
  Stemline Therapeutics� (NASDAQ: STML  ) has only traded publicly this year, but what a year it's been. The stock's performance ranks Stemline as the best-performing biotech IPO so far in 2013. This week has been pretty good also, with shares moving up by 28%.

Top 10 Up And Coming Stocks To Own Right Now: Revive Therapeutics Ltd (RVV)

Revive Therapeutics Ltd., formerly Mercury Capital II Limited, is focused on acquiring, developing and commercializing treatments for major market opportunities such as sleep apnea, gout and rare diseases. The Company is focused on underserved medical needs such as opioid-induced respiratory depression in high risk patients with sleep apnea, gout, and Rett Syndrome. The Company is also developing a next generation analog of REV-001, which is an improvement of the original compound and it will have the potential to treat new diseases that would otherwise remain untreated with the original compound, such as rare diseases, breathing disorders, and cognitive dysfunction. Advisors' Opinion:

• [By Holly LaFon]

  Whitney George is Director of Investments, Managing Director, and a Portfolio Manager of Royce & Associates, LLC, investment advisor to The Royce Funds. He serves as portfolio manager for Royce Premier Fund (RPR), Royce Low-Priced Stock Fund (RLP), Royce Global Value Fund (RGV), Royce SMid-Cap Value Fund (RSV), and Royce Focus Trust (FUND). He also serves as assistant portfolio manager for Royce Micro-Cap Fund (RMC), Royce Value Fund (RVV), Royce Value Plus Fund (RVP), Royce Focus Value Fund (RFV), and Royce Capital Fund ��Micro-Cap Portfolio (RCM). Mr. George's thoughts in this interview concerning the stock market are solely his own and, of course, there can be no assurance with regard to future market movements.

Top 10 Up And Coming Stocks To Own Right Now: Bank of Nova Scotia (BNS)

The Bank of Nova Scotia (the Bank) is a diversified financial institution. As of October 31, 2011, the Bank offered a range of products and services, including retail, commercial, corporate and investment banking to more than 18.6 million customers in more than 50 countries around the world. The Bank has four business lines: Canadian Banking, International Banking, Scotia Capital and Global Wealth Management. In January 2012, the Company closed its acquisition of 51% of Banco Colpatria. In April 2012, the Company through Scotia Capital Inc. acquired Howard Weil Incorporated. In April 2013, Bank of Nova Scotia acquired a 50% interest in Administradora de Fondos de Pensiones Horizonte SA. Advisors' Opinion:

• [By Will Ashworth]

  TD Rating: 7.5

  Bank of Nova Scotia (BNS)

  Dividend Yield: 3.9%

  The last of the major Canadian banks is Bank of Nova Scotia (BNS). Not known for its Canadian retail banking, its biggest calling cards are its businesses outside of Canada in Latin America and Asia. Analysts expect it to deliver a 9.1% increase in adjusted net income in the fourth quarter to C$1.6 billion, 47% of which will come from outside of Canada.

• [By MONEYMORNING.COM]

  The London Silver Market Fixing Ltd. currently operates with just three members: Deutsche Bank AG (USA) (NYSE: DB), HSBC Holdings Plc. (NYSE ADR: HSBC), and Bank of Nova Scotia (USA) (NYSE: BNS).

• [By Dan Caplinger]

  On Tuesday, Bank of Nova Scotia (NYSE: BNS  ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed, kneejerk reaction to news that turns out to be exactly the wrong move.

Top 10 Up And Coming Stocks To Own Right Now: Jinzanghuang Tibet Pharmaceuticals Inc (JZHG)

Jinzanghuang Tibet Pharmaceuticals, Inc. distributes Tibetan pharmaceutical and nutraceutical products in the People�� Republic of China (PRC) through Leling Jinzanghuang Biotech Co., Ltd. (Leling JZH). The Company, through its wholly owned subsidiary, Tibet Medicine, Inc., owns 100% of Beijing Taibodekang Consulting Co., Ltd. (Beijing Taibodekang), a wholly foreign owned entity. Beijing Taibodekang had entered into four agreements with Leling Jinzanghuang Biotech Co., Ltd. (Leling Jinzanghuang) and with the equity owners in Leling Jinzanghuang. Collectively, the agreements provide Beijing Taibodekang exclusive control over the business of Leling Jinzanghuang. Leling Jinzanghuang engages in the distribution of the pharmaceutical and nutraceutical products that Tibetans have used for centuries to treat diseases and facilitate health. The distributed products are classified by Leling Jinzanghuang in three major categories: pharmaceuticals, therapeutic supplements, and dietary supplements.

The 13 Tibetan health products that Leling Jinzanghuang distributes are among those Tibetan medicines made with modern drug manufacturing techniques. The manufacturing equipment and techniques used by its supplier are certified under China�� national standards of Good Manufacturing Practice (GMP), and are in compliance with applicable regulations of the Chinese Food and Drug Administration (SFDA), which regulates both the pharmaceutical and the nutraceutical industries in China.

Ying Huang Tablet

Ying Huang Tablet is one the two pharmaceutical products marketed by Leling Jinzanghuang that been approved by SFDA. The effective ingredients in the Ying Huang Tablet are extracts from the honeysuckle and the Huangqin herb. It can be used to treat upper respiratory infections including pharyngitis, encephalitis and conjunctivitis. It can also be used to reduce inflammation and relieve pain.

San Qi Capsules

San Qi Capsules is a dietary supplements certified! by SFDA. San Qi Capsules lower blood lipid and cholesterol levels. Thus they can be used as a precautionary therapy to prevent cardiovascular diseases, including coronary heart disease, heart angina and stroke. In addition, the San Qi Capsules enhance immune system functions, which may help in the prevention of cancer.

Foshou Capsules

Foshou Capsules is a Tibetan nutraceutical. The effective ingredients, Xue Yu, Dongchong Xiacao, Fozhang, and Ginseng, are extracts of several plants and animals that are native to the Tibet Plateau.

Bai He Capsules

Bai He Capsules is a Tibetan dietary supplement. The effective ingredients consist of Baihe, Fozhang Ginseng and Himalayan purple jasmine. The Bai He Capsules are used to treat male erectile dysfunction and other sexual dysfunction problems.

The Company competes with Jingqiu Tibetan Medicine, Jinhe Tibetan Medicine and Tibetan Pharmaceutical Factory, Tibet Cheezheng Tibetan Medicine and Niemula Tibet Medicine.

Advisors' Opinion:

• [By Peter Graham]

  Small cap medical technology stock Sanomedics International Holdings (OTCMKTS: SIMH) recently completed financing and an acquisition while JinZangHuang Tibet Pharmaceuticals, Inc (OTCMKTS: JZHG) surged 48.28% on Friday. However, that�� only part of the story as one of these stocks has been the subject of paid promotions while the other has no new news for investors. So are either of these small cap stocks the cure for any portfolio pains you may be suffering from? Here is a quick reality check:

Top 10 Up And Coming Stocks To Own Right Now: ALCO Stores Inc (ALCS)

Alco Stores, Inc., incorporated on June 2, 1915, is engaged in the business of retailing general merchandise throughout the central portion of the United States of America through a range of department store outlets. The Company�� ALCO stores offer a range of merchandise consisting of approximately 35,000 items, including automotive, commodities, crafts, domestics, electronics, furniture, hardware, health and beauty aids, housewares, jewelry, ladies�� men�� and children�� apparel and shoes, pre-recorded music and video, sporting goods, seasonal items, stationery and toys.

As of February 3, 2013, the Company operated 217 stores in 23 states located in mostly smaller communities in the central United States. The stores average approximately 21,000 square feet of selling space, with an additional 5,000 square feet utilized for merchandise processing, temporary storage and administration.

Advisors' Opinion:

• [By Monica Gerson]

  ALCO Stores (NASDAQ: ALCS) is projected to post its Q2 earnings.

  Digital Cinema Destinations (NASDAQ: DCIN) is estimated to post a Q4 loss at $0.11 per share on revenue of $11.17 million.